Investigation of effects of angiotensin type 2 receptors on extracellular matrix synthesis for renal therapy
Investigation of effects of angiotensin type 2 receptors on extracellular matrix synthesis for renal therapy
批准号:
12671047
负责人:
SASAMURA Hiroyuki
金额:
$1.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this study, we examined the effects of angiotensin II type 1 (ATI) and type 2 (AT2) receptor stimulation on synthesis of extracellular matrix proteins, including collagen and proteoglycans using a vascular smooth muscle cell line (VSMG-AT2) expressing AT2 receptors. Stimulation of these cells with the AT2 receptor agonist CGP42112A did not cause a significant change in ERK1/2 activity but caused a small but significant decrease in protein tyrosine phosphatase activity. The stimulation of the AT2 receptor also caused a dose- and time-dependent increase in both cell-associated and secreted collagen synthesis to 148+17% of control levels (p<0.05), The effects of AT1 and AT2 receptor stimulation on proteoglycan synthesis were next examined. Stimulation of the AT1 receptor caused a dose- and time-dependent increase in proteoglycan synthesis. DEAE-Sephacel chromatography revealed an increase in both HSPG and CS/DSPG, while Northern blot analysis showed' that biglycan, versican, and perlecan mRNA were increased, Stimulation of the AT2 receptor alone also caused a small but significant increase in proteoglycan synthesis which was unaffected by tyrosine kinase and MEK inhibitors but attenuated by pertussis toxin. In vivo studies using angiotensin receptor blocker (ARB) showed that ARB treatment caused a decrase in biglycan and decorin mRNA but an increase in versican mRNA. These results suggested that angiotensin II can regulate extracellular matrix synthesis by both AT1 and AT2 receptors through multiple mechanisms.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sasamura., et al.: "Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats"Hypertension Research. 24. 165-172 (2001)
Sasamura., et al.:“AT1 受体拮抗剂对高血压大鼠蛋白多糖基因表达的影响”高血压研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakaya et al.: "Temporary treatment of piepubescent rats with angiotensin inhibitors suppresses the development of hypertersive nephrosderasis"Journal of the American Society of Nephrology. 12(4). 659-666 (2001)
Nakaya 等人:“用血管紧张素抑制剂临时治疗青春期大鼠可抑制高血压性肾病的发展”美国肾脏病学会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mifune., et al.: "Examination of angiotensin II type 1 and type 2 receptor exprossion in human kidneys by immunohertocle Minitry"Clinnal and Expermental Hypertension. 23. 257-266 (2001)
Mifune., et al.:“通过免疫赫托克Minitry检查人肾中血管紧张素II 1型和2型受体表达”临床和实验性高血压。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinizu-Hirota., et al.: "Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors"Journal of the American Society of Nephrology. 12. 2609-2615 (2001)
Shinizu-Hirota., et al.:“血管紧张素 II 1 型和 2 型受体对血管蛋白多糖合成的调节”美国肾病学会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H. Sasamura, R. Shimizu-Hirota, H. Nakaya, T. Saruta: "Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats"Hypertension Research. 24. 165-172 (2001)
H. Sasamura、R. Shimizu-Hirota、H. Nakaya、T. Saruta:“AT1 受体拮抗剂对高血压大鼠蛋白多糖基因表达的影响”高血压研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Analysis of salt memory in hypertension and its molecular mechanism
-
批准号:23591225
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2011
-
负责人:SASAMURA Hiroyuki
-
依托单位:
Regression of hypertension : molecular analysis and epigenetic assessment
-
批准号:20590984
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2008
-
负责人:SASAMURA Hiroyuki
-
依托单位:
Role of collagenases and gelatinases in renal injury and their, therapeutic applications
-
批准号:17590844
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.39万
-
财政年份:2005
-
负责人:SASAMURA Hiroyuki
-
依托单位:
Mechanisms of attenuation of renal injury in biglycan transgenic mice
-
批准号:14571036
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2002
-
负责人:SASAMURA Hiroyuki
-
依托单位:
INVESTIGATION OF SIGNAL TRANSDUCTION AND ANTI-PROLIPERATIVE ACTIONS OF ANGIOTENSIN II TYPE 2 PECEPTOR
-
批准号:10671005
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.96万
-
财政年份:1998
-
负责人:SASAMURA Hiroyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
-
批准号:82371007
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:雷浪
-
依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:傅强
-
依托单位:
丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
-
批准号:81903932
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:龚陈媛
-
依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究
-
批准号:81970025
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:高金明
-
依托单位:
无脊椎动物新型受体Parathyroid hormone receptor like (PTHRL) 的鉴定及其对赤拟谷盗表皮发育的调控
-
批准号:31872970
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:李斌
-
依托单位:
衰老过程中Lamin-B Receptor蛋白聚积通过扰乱干细胞竞争促进生殖干细胞丢失的分子机制研究
-
批准号:31671254
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2016
-
负责人:陈海洋
-
依托单位:
Leptin Receptor负向调控应力刺激诱导的后纵韧带骨化的分子机制及转化研究
-
批准号:81401821
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:陈剑
-
依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
-
批准号:31270835
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张云
-
依托单位:
受体相互作用蛋白3(Receptor-interacting protein 3,RIP3)调控神经元缺血性程序性坏死的作用及机制研究
-
批准号:81271272
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:罗本燕
-
依托单位:
Retinoid X Receptor(RXR)α启动子甲基化在结直肠癌发生发展中的作用
-
批准号:81201582
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:张芬芬
-
依托单位: